Kessler Investment Group Raised Its Stake in General Electric Co (GE) by $2.12 Million as Stock Value Declined; Spark Investment Management Has Raised Seattle Genetics (SGEN) Stake by $4.43 Million

October 12, 2017 - By Vivian Currie

Kessler Investment Group Llc increased its stake in General Electric Co (GE) by 1366.97% based on its latest 2017Q2 regulatory filing with the SEC. Kessler Investment Group Llc bought 78,601 shares as the company’s stock declined 7.64% while stock markets rallied. The institutional investor held 84,351 shares of the consumer electronics and appliances company at the end of 2017Q2, valued at $2.28M, up from 5,750 at the end of the previous reported quarter. Kessler Investment Group Llc who had been investing in General Electric Co for a number of months, seems to be bullish on the $198.96B market cap company. The stock declined 0.33% or $0.07 reaching $23 on the news. About 13.36M shares traded. General Electric Company (NYSE:GE) has declined 4.46% since October 12, 2016 and is downtrending. It has underperformed by 21.16% the S&P500.




Spark Investment Management Llc increased its stake in Seattle Genetics Inc (SGEN) by 166.48% based on its latest 2017Q2 regulatory filing with the SEC. Spark Investment Management Llc bought 86,900 shares as the company’s stock rose 1.68% with the market. The hedge fund held 139,100 shares of the health care company at the end of 2017Q2, valued at $7.20M, up from 52,200 at the end of the previous reported quarter. Spark Investment Management Llc who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $8.63 billion market cap company. The stock declined 1.89% or $1.16 reaching $60.31 on the news. About 603,275 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since October 12, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Among 16 analysts covering Seattle Genetics (NASDAQ:SGEN), 6 have Buy rating, 1 Sell and 9 Hold. Therefore 38% are positive. Seattle Genetics had 45 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, July 27 by Cantor Fitzgerald. Goldman Sachs upgraded the shares of SGEN in report on Thursday, September 15 to “Neutral” rating. Oppenheimer initiated the stock with “Hold” rating in Tuesday, October 10 report. H.C. Wainwright maintained the shares of SGEN in report on Monday, June 19 with “Buy” rating. The rating was maintained by J.P. Morgan with “Hold” on Thursday, June 8. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Hold” rating given on Thursday, June 15 by Oppenheimer. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Hold” rating by SunTrust on Tuesday, October 3. The company was maintained on Friday, June 2 by Oppenheimer. RBC Capital Markets maintained it with “Outperform” rating and $62 target in Monday, October 10 report. The firm earned “Sell” rating on Wednesday, November 18 by Goldman Sachs.

Investors sentiment decreased to 1.3 in 2017 Q2. Its down 0.20, from 1.5 in 2017Q1. It dropped, as 30 investors sold SGEN shares while 75 reduced holdings. 48 funds opened positions while 89 raised stakes. 137.48 million shares or 0.82% less from 138.62 million shares in 2017Q1 were reported. Art Advsr Limited Liability Corp accumulated 6,275 shares. Florida-based Carl Domino has invested 0.31% in Seattle Genetics, Inc. (NASDAQ:SGEN). Bluemountain Lc has invested 0.02% in Seattle Genetics, Inc. (NASDAQ:SGEN). Strs Ohio stated it has 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Nbt Fincl Bank N A Ny accumulated 18,770 shares or 0.16% of the stock. M&T State Bank Corporation stated it has 4,173 shares. Comerica National Bank has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Georgia-based Invesco has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). 20,200 are owned by Tributary Mgmt Ltd Liability Company. Pathstone Family Office Ltd has invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). 25,017 were accumulated by Berson & Corrado Investment Advsr Llc. Bnp Paribas Arbitrage Sa invested in 17,809 shares or 0% of the stock. Gotham Asset Mngmt Lc holds 0.02% or 31,269 shares. Commerzbank Aktiengesellschaft Fi has invested 0.04% in Seattle Genetics, Inc. (NASDAQ:SGEN). Raymond James Advsrs reported 4,675 shares.

More notable recent Seattle Genetics, Inc. (NASDAQ:SGEN) news were published by: Zacks.com which released: “Seattle Genetics Inks Clinical Collaborations for Cancer Drug” on October 12, 2017, also Seekingalpha.com with their article: “Seattle Genetics: Good Time To Buy Based On Adcetris Label Expansion” published on September 15, 2017, Businesswire.com published: “Seattle Genetics to Host Conference Call and Webcast Discussion of Third …” on October 05, 2017. More interesting news about Seattle Genetics, Inc. (NASDAQ:SGEN) were released by: Nasdaq.com and their article: “Seattle Genetics’ Adcetris Gets Breakthrough Therapy Status” published on October 03, 2017 as well as Streetinsider.com‘s news article titled: “Seattle Genetics (SGEN) & Astellas Commences Pivotal Trial of Enfortumab Vedotin” with publication date: October 10, 2017.

Since May 5, 2017, it had 0 buys, and 3 selling transactions for $2.20 million activity. The insider SIEGALL CLAY B sold 14,462 shares worth $892,897.

Spark Investment Management Llc, which manages about $1.26 billion and $1.62 billion US Long portfolio, decreased its stake in Tesaro Inc (NASDAQ:TSRO) by 19,600 shares to 38,700 shares, valued at $5.41 million in 2017Q2, according to the filing. It also reduced its holding in Sanmina Corporation (NASDAQ:SANM) by 30,100 shares in the quarter, leaving it with 70,700 shares, and cut its stake in Hci Group Inc (NYSE:HCI).

Since May 15, 2017, it had 3 insider buys, and 0 sales for $3.37 million activity. Another trade for 4,000 shares valued at $110,800 was bought by Beattie William G.

Investors sentiment decreased to 0.79 in 2017 Q2. Its down 0.03, from 0.82 in 2017Q1. It worsened, as 85 investors sold GE shares while 816 reduced holdings. 111 funds opened positions while 598 raised stakes. 4.61 billion shares or 0.66% more from 4.58 billion shares in 2017Q1 were reported. Bainco Int has 268,088 shares. Jones Financial Lllp invested in 114,664 shares or 0.01% of the stock. Southeast Asset Advsr, a Georgia-based fund reported 15,567 shares. Douglass Winthrop Llc reported 236,070 shares stake. Joel Isaacson And Lc invested in 0.76% or 149,317 shares. Clark Capital Group Inc stated it has 0.07% of its portfolio in General Electric Company (NYSE:GE). Reaves W H has invested 0.01% of its portfolio in General Electric Company (NYSE:GE). Wendell David Associate Inc has invested 0.41% in General Electric Company (NYSE:GE). Puplava Finance Serv Inc owns 11,209 shares for 0.16% of their portfolio. Marathon has invested 1.45% in General Electric Company (NYSE:GE). Cornerstone Inc reported 22,190 shares stake. Oakworth Capital owns 49,282 shares or 0.36% of their US portfolio. Salient Cap Advsr Limited Company accumulated 0.03% or 59,286 shares. Private Wealth Prtn Limited Liability reported 1.38% stake. Nichols And Pratt Advisers Ltd Liability Partnership Ma reported 2.15 million shares stake.

More notable recent General Electric Company (NYSE:GE) news were published by: Seekingalpha.com which released: “General Electric: Table Set For Dividend Cut” on October 12, 2017, also Seekingalpha.com with their article: “GE’s Leadership Changes: A Small But Positive Step” published on October 09, 2017, Seekingalpha.com published: “General Electric: Immelt Out. Was That The Bottom?” on October 02, 2017. More interesting news about General Electric Company (NYSE:GE) were released by: Seekingalpha.com and their article: “General Electric Returning To Its Industrial Roots” published on October 11, 2017 as well as Forbes.com‘s news article titled: “Earnings Results Are Unlikely To Reverse GE Stock’s Massive 2017 Decline” with publication date: October 11, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: